首页 | 本学科首页   官方微博 | 高级检索  
     


Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised,controlled, phase 3 trial
Authors:Paul E Goss  Ian E Smith  Joyce O'Shaughnessy  Bent Ejlertsen  Manfred Kaufmann  Frances Boyle  Aman U Buzdar  Pierre Fumoleau  William Gradishar  Miguel Martin  Beverly Moy  Martine Piccart-Gebhart  Kathleen I Pritchard  Deborah Lindquist  Yanin Chavarri-Guerra  Gursel Aktan  Erica Rappold  Lisa S Williams  Dianne M Finkelstein
Affiliation:1. Massachusetts General Hospital, Boston, MA, USA;2. Royal Marsden Hospital, London, UK;3. Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA;4. Rigshospitalet, DBCG Secretariat, Copenhagen, Denmark;5. JW Goethe-Universität, Frankfurt, Germany;6. Mater Hospital, North Sydney, NSW, Australia;7. University of Texas MD Anderson Cancer Center, Houston, TX, USA;8. Centre GF Leclerc, Dijon, France;9. Northwestern University, Chicago, IL, USA;10. Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain;11. Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium;12. Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada;13. Arizona Oncology, US Oncology, Sedona, AZ, USA;14. GlaxoSmithKline, Collegeville PA, USA;15. GlaxoSmithKline, Uxbridge, UK
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号